Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fabbri

Showing results (331-340 of 370) with videos related to

Pageof 37
Sort By:
Journal of Endocrinological Investigation|February 27, 2017
The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosisJ Pepe, C Cipriani, F P Cantatore, et al.
Giornale Italiano Di Cardiologia|January 1, 1982
[The fate of patients treated with a bypass. Long-term results]S Dalla Volta, F Corbara, C Di Mario, et al.
Leukemia Research|August 4, 2009
Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2'-deoxyadenosine (2-CdA) and RituximabC Rabascio, D Laszlo, G Andreola, et al.
British Journal of Cancer|January 24, 2008
First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II studyC Tibaldi, E Vasile, A Antonuzzo, et al.
Leukemia & Lymphoma|October 31, 2006
CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphomaF Zaja, V Tomadini, A Zaccaria, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 22, 2023
A comprehensive review of healthy effects of vegetarian dietsC Agnoli, L Baroni, I Bertini, et al.
Current Cancer Drug Targets|August 12, 2008
FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancerD L Cortinovis, F Andriani, A Livio, et al.
Frontiers in Microbiology|January 8, 2015
LDS1-produced oxylipins are negative regulators of growth, conidiation and fumonisin synthesis in the fungal maize pathogen Fusarium verticillioidesValeria Scala, Paola Giorni, Martina Cirlini, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 6, 2000
Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcomaT Mancuso, A Mezzelani, C Riva, et al.
Investigational New Drugs|February 19, 2013
Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective studyLuca Moscetti, Fabrizio Nelli, Maria A Fabbri, et al.
Pageof 37

Showing results (331-340 of 370) with videos related to

Sort By:
Pageof 37
Journal of Endocrinological Investigation|February 27, 2017
The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosisJ Pepe, C Cipriani, F P Cantatore, et al.
Giornale Italiano Di Cardiologia|January 1, 1982
[The fate of patients treated with a bypass. Long-term results]S Dalla Volta, F Corbara, C Di Mario, et al.
Leukemia Research|August 4, 2009
Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2'-deoxyadenosine (2-CdA) and RituximabC Rabascio, D Laszlo, G Andreola, et al.
British Journal of Cancer|January 24, 2008
First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II studyC Tibaldi, E Vasile, A Antonuzzo, et al.
Leukemia & Lymphoma|October 31, 2006
CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphomaF Zaja, V Tomadini, A Zaccaria, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 22, 2023
A comprehensive review of healthy effects of vegetarian dietsC Agnoli, L Baroni, I Bertini, et al.
Current Cancer Drug Targets|August 12, 2008
FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancerD L Cortinovis, F Andriani, A Livio, et al.
Frontiers in Microbiology|January 8, 2015
LDS1-produced oxylipins are negative regulators of growth, conidiation and fumonisin synthesis in the fungal maize pathogen Fusarium verticillioidesValeria Scala, Paola Giorni, Martina Cirlini, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 6, 2000
Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcomaT Mancuso, A Mezzelani, C Riva, et al.
Investigational New Drugs|February 19, 2013
Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective studyLuca Moscetti, Fabrizio Nelli, Maria A Fabbri, et al.
Pageof 37